John G. Gerber

4.9k citations
84 papers · 3.9k · h-index 33

Impact in

Papers in

    • HIV/AIDS drug development and treatment 28
    • HIV/AIDS Research and Interventions 8
    • HIV Research and Treatment 20

John G. Gerber

81 papers receiving 3.7k citations

Peers

John G. Gerber
Comparison fields: 5 of 123
  • Virology 902
  • Emergency Medicine 1.2k
  • Infectious Diseases 1.5k
  • Pharmacology 328
  • Biochemistry 196
Replace G. Richard Granneman with:
G. Richard Granneman United States
Jérôme Biollaz Switzerland
Catia Marzolini Switzerland
Saı̈k Urien France
Richard C. Brundage United States
Richard Bertz United States
Eleni Aklillu Sweden
Elisabeth Rey France
Zeruesenay Desta United States
Bruno Lacarelle France
John G. Gerber relative to G. Richard Granneman United States G. Richard Granneman's profile →
Citations per field
00.5×3.8×
G. Richard Granneman · 1×
Citations per year

Countries citing papers authored by John G. Gerber

Since Specialization
Citations

This map shows the geographic impact of John G. Gerber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John G. Gerber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John G. Gerber more than expected).

Fields of papers citing papers by John G. Gerber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John G. Gerber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John G. Gerber. The network helps show where John G. Gerber may publish in the future.

Co-authors

The 25 scholars most cited alongside John G. Gerber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John G. Gerber Line = papers co-authored together John G. Gerber links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 84 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2003466
2 2002295
3 2002273
4 2003197
5 1981184
6 2003141
7 2002140
8 2005136
9 1978129
10 2008121
11 200291
12 200871
13 199970
14 200567
15 200163
16 200362
17 200459
18 198156
19 198553
20 199852

About John G. Gerber

John G. Gerber is a scholar working on Infectious Diseases, Virology, Pharmacology, Emergency Medicine and Biochemistry, having authored 84 papers that have together received 3.9k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (28 papers), HIV Research and Treatment (20 papers), Inflammatory mediators and NSAID effects (17 papers), HIV-related health complications and treatments (12 papers), Eicosanoids and Hypertension Pharmacology (10 papers), HIV/AIDS Research and Interventions (8 papers), Hormonal and reproductive studies (6 papers) and Pharmacogenetics and Drug Metabolism (6 papers). The work is most often cited by research in Virology (902 citations), Emergency Medicine (1.2k citations), Infectious Diseases (1.5k citations), Pharmacology (328 citations) and Biochemistry (196 citations). John G. Gerber has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Alan S. Nies, Carl J. Fichtenbaum, Judith A. Aberg, Edward P. Acosta, J. Gál, Judith S. Currier, Michael P. Dubé, Susan L. Rosenkranz, Robert J. Rhodes and Richard D. Olson. Their work appears in journals such as Clinical Pharmacology & Therapeutics, JAIDS Journal of Acquired Immune Deficiency Syndromes, Prostaglandins, The Journal of Infectious Diseases and Chirality.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact